Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Avexa initiates two phase III clinical trials of apricitabine for drug-resistant HIV

Nov. 23, 2007

Recent GSK patents impart new agents for HIV infection

Nov. 22, 2007

MSD's Isentress for HIV-1 infection gets positive opinion from CHMP

Nov. 21, 2007

Prime-boost regimens with ALVAC-HIV prime tested in healthy volunteers

Nov. 16, 2007

TMC-125: Study results presented at the 11th European AIDS Conference

Nov. 15, 2007

Recent Tibotec and Pfizer patents report new therapeutic agents for HIV infection

Nov. 14, 2007

Pharmexa reports positive preliminary results from the HVTN 064 phase I trial of EP-1043

Nov. 14, 2007

FDA grants approval to Abbott for lower-strength tablet formulation of Kaletra tablet

Nov. 13, 2007

STEP study confirms Merck & Co.'s investigational HIV vaccine V-520 was not effective

Nov. 9, 2007

Phase I studies delineate pharmacokinetics of elvitegravir in healthy volunteers

Nov. 9, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...